Fiona Coats Appointed Chief Marketing Officer at Refeyn

Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024. Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.

Educated in the UK, Fiona Coats holds a Ph.D. in Physiology/Pharmacology and a B.Sc. in Pharmacology, and has successfully leveraged her scientific insights to excel in strategic marketing and drive business expansion. Her career highlights include spearheading revenue growth, crafting cutting-edge go-to-market strategies, and overseeing product management within the competitive life science research arena.

Fiona’s professional journey includes pivotal roles at Biosource International, Meso Scale Diagnostics, ThermoFisher Scientific and more recently at Sartorius, where she has consistently excelled in building brands and expanding market presence. She has managed global teams and budgets with a focus on transformative returns through innovative marketing strategies targeting attractive growth segments. As she takes on the role of Chief Marketing Officer, Fiona’s expertise is expected to drive the company’s growth and solidify its market position. Her dynamic and informed marketing leadership is set to propel the company towards a future of sustained success.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.